This section is not available in the published analysis.
EpiSwitch® Platform: Audience
The EpiSwitch® Platform offers advanced clinical smart tests that utilize 3D gene regulation technology to aid in precision medicine. It provides accurate assessments for prostate cancer risk and therapeutic success of cancer treatments.